For licensed healthcare professionals. The protocol figures below are drawn from published labeling and peer-reviewed literature for educational reference. They are not a prescription, not a recommendation, and not a substitute for the dispensing pharmacy's labeling or your own clinical judgment.

GH Secretagogue

IGF-1 LR3

aka Long R3 IGF-1

Research onlyWADA prohibited

Long-acting IGF-1 analog with extended half-life via reduced IGFBP binding. WADA-prohibited.

At a glance

Common vial size: 1 mg
Reference dose: 40 mcg
Frequency: Once daily

Reference titration protocol

40 mcg once daily; hypoglycemia risk — dose post-meal.

Reference titration ladder for IGF-1 LR3
Step	Dose	Duration	Administrations / week
1	40 mcg	4 weeks	7×

Reconstitution example

A 1 mg vial reconstituted with 1 mL of bacteriostatic water yields 1 mg/mL. Confirm the diluent and volume against the labeling that ships with the vial.

Open this configuration in the calculator

Clinical notes

Hypoglycemia risk — dose post-meal

Available formulations

Presentations carried across the VitaRelay pharmacy network, including 503A compounded, 503B outsourcing facility, and research & development sourcing. Pricing and state-level availability are shown to verified accounts only.

Lyophilized PowderR&D

Pricing and ordering are for verified accounts

VitaRelay serves licensed practices, prescribers, and pharmacies. Catalog pricing, availability by state, and ordering are available after your account is verified.

Request access Sign in

Also in GH Secretagogue

Sermorelin

GHRH 1-29 analog that stimulates pulsatile endogenous GH release. Historically FDA-approved (Geref, withdrawn 2008); now compounded.

Tesamorelin

Stabilized GHRH analog FDA-approved for HIV-associated lipodystrophy. Often compounded with ipamorelin in anti-aging protocols.

Ipamorelin

Selective ghrelin/GHS-R agonist that triggers pulsatile GH release with minimal cortisol or prolactin impact. WADA-prohibited.

CJC-1295 (no DAC)

GHRH analog often stacked with ipamorelin to amplify endogenous GH pulses. WADA-prohibited.

GHRP-2

Synthetic hexapeptide ghrelin-receptor agonist. Stronger GH release than GHRP-6 with less appetite stimulation.

GHRP-6

Ghrelin-receptor agonist with marked appetite-stimulant effect. Often stacked with a GHRH (sermorelin or CJC-1295).

Educational information for licensed healthcare professionals

The material on this page is general educational information intended for licensed healthcare professionals and their clinical staff. It is not medical advice, is not a substitute for professional judgment, and does not establish a provider-patient relationship. Nothing here should be read as a recommendation for, or endorsement of, any specific therapy, product, or course of treatment. Compounded preparations must be handled in accordance with applicable federal and state law, the dispensing pharmacy's labeling, and your own institutional policies. All clinical decisions — including product selection, preparation, dosing, and administration — remain the sole responsibility of the treating licensed practitioner.

VitaRelay is a technology and logistics network. We are not a pharmacy, prescriber, or distributor. See our Terms of Service and service availability for details.